Historical salary details - Ms. Sandra A. Gardiner, Interim Chief Financial Officer and Principal Accounting Officer, Nektar Therapeutics
Ms. Sandra A. Gardiner has been the Interim Chief Financial Officer and Principal Accounting Officer of Nektar Therapeutics since 18 Mar 2023. View his historical salary.
Ms. Sandra A. Gardiner
Interim Chief Financial Officer and Principal Accounting Officer
-
Gross Remuneration
-
Current Company
Nektar Therapeutics
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Nektar Therapeutics | Interim Chief Financial Officer and Principal Accounting Officer | - | - |
| 2023 | Nektar Therapeutics | Interim Chief Financial Officer and Principal Accounting Officer | 376.3 K | - |